Abstract
The present study focuses on developing a new metal matrix composite from commercially pure titanium grade 2 and metal oxides of interest to the biomedical field (TiO2, Al2O3, MoO3, MnO2, and Fe2O3) as reinforcement. The composite will be formed by argon arc-melting, with a mixture of oxide particles in the proportion of 5% volumetric to titanium. The composite will subsequently be subjec…